Business Description
Gelesis Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US36850R2040
Description
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -61.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -414.58 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GLSHQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gelesis Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.14 | ||
| EPS (TTM) ($) | -0.7 | ||
| Beta | 0 | ||
| Volatility % | 66.81 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000051 | ||
| 20-Day SMA ($) | 0.000428 | ||
| 12-1 Month Momentum % | -61.82 | ||
| 52-Week Range ($) | 0.00001 - 0.02 | ||
| Shares Outstanding (Mil) | 73.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gelesis Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gelesis Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gelesis Holdings Inc Frequently Asked Questions
What is Gelesis Holdings Inc(GLSHQ)'s stock price today?
The current price of GLSHQ is $0.00. The 52 week high of GLSHQ is $0.02 and 52 week low is $0.00.
When is next earnings date of Gelesis Holdings Inc(GLSHQ)?
The next earnings date of Gelesis Holdings Inc(GLSHQ) is 2024-12-27 Est..
Does Gelesis Holdings Inc(GLSHQ) pay dividends? If so, how much?
Gelesis Holdings Inc(GLSHQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers